← Leaderboards
Adam Leaman
Leidos Biomedical Research, Inc.
$10,693,302
Attributed
$10,693,302
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.5M · FY2019–23$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,693,302 · 1
By mechanism
N01$9,486,322 · 1
N02$1,206,980 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- Ethan Dmitrovsky$597,515,186
- Leonard Freedman$1,216,107,431
- Gautam (george) Mitra$53,523,213
- Lynn Briscoe$495,968,635
Others in their field
Other Emerging Leaders on “Cell Therapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,831,044
- Bronwen Shaw · Medical College Of Wisconsin$24,206,529
- Gary Fanger · Rise Therapeutics, Llc$20,770,458
Research focus
Cell Therapy